Search Videos and More
Course
Diagnosing the Apical Variant of Hypertrophic Cardiomyopathy
A 60-year-old man with a history of hypertension was admitted to the hospital after three days of a drooping face and right arm weakness. He had no chest pain or shortness of breath, and no prior history of irregular heartbeat. However, his echocardiogram was abnormal, and his high sensitivity troponin level was mildly to moderately elevated. Doctors ordered STAT echocardiogram with saline contrast, but the initial images were perplexing – normal left ventricle function, no evidence of systolic anterior motion, and nothing to suggest an LVOT obstruction.
News
Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective therapies, we bring hope to patients with serious and debilitating lung diseases.
Video
What is new in 2024 for PE
A comprehensive overview of strategic clinical risk stratification, evidence-based approaches derived from clinical trials and advanced research, and essential insights into the follow-up care of patients post-pulmonary embolism (PE).
Course
Breaking Down Updated Aortic Guidelines for Echocardiographers
In 2022, the American College of Cardiology and the American Heart Association released updated aortic guidelines that synthesized some 20 separate guidelines issued by nearly as many organizations over the previous 12 years.
Course
Technology Update: Redefining Echocardiography Diagnostics and Education with AI, AR, and Beyond
For a photographer or videographer, it’s second nature to use lighting to get a better view of a subject. But few cardiac imagers think about moving light sources within the heart.
Course
2024 GOLD International COPD Conference
Join us on November 11th and 12th for the world’s largest educational symposium on chronic obstructive pulmonary disease (COPD). The upcoming 9th annual GOLD International COPD Conference is once again a two-day event hosted in Philadelphia, Pennsylvania.
Course
An Overview of Common Complications with Structural Heart Disease
The leading treatment option for AS and other structural diseases is transcatheter aortic valve replacement (TAVR). The overall complication rate of TAVR is relatively low -- around 4%. However, patients who experience complications have increased hospital lengths-of-stay and higher one-year mortality rates
Video
Pulmonary Arterial Hypertension and RV Failure
The average time from symptom onset to accurate diagnosis of pulmonary arterial hypertension (PAH) is 2.8 years, and more than half of patients have already progressed to functional class 3 or 4 by the time of diagnosis. Overlapping symptoms and clinical presentations can make it challenging to classify pulmonary hypertension patients correctly.
Course
Pleural Effusions and Pleural Disease
Pleural disease is a common but frequently misunderstood clinical entity within the field of pulmonary disease. While up to 30% of individuals assessed may have pleural effusions, the specific diagnostic and therapeutic modalities undertaken have significant downstream implications for the diagnostic yield of studies, potential complication profile, and in the setting of therapeutic procedures, the extent to which these can either help to facilitate overall treatment or to reduce symptom burden in the case of palliative-type procedures such as tunneled pleural catheters or chemical pleurodesis for malignant pleural effusions.
Video
REBIRTH Trial: Evaluating Bromocriptine Therapy for Peripartum Cardiomyopathy
In this presentation, Dr. Deborah Crabbe, Cardiologist at Temple University Hospital and Professor of Medicine at Lewis Katz School of Medicine at Temple University, outlines the REBIRTH Trial, a randomized trial that reviews the use of bromocriptine therapy for the treatment of peripartum cardiomyopathy (PPCM)
News
Update for Providers: Temple Healthy Chest Initiative’s Dual Screening Referral Process
News
Benign Prostatic Hyperplasia
With one of the largest and most experienced urology teams in the region and the latest treatment capabilities, the Fox Chase-Temple Urologic Institute is a trusted leader in treating all types of urologic conditions.